Murine mammary gland carcinogenesis is critically dependent on progesterone receptor function

Cancer Research

Volumn 59, Issue 17, 1999, Pages 4276-4284

  Lydon, John P ^a   Ge, Gouqing ^a   Kittrell, Francis S ^a   Medina, Daniel ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; PROGESTERONE RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HORMONE ACTION; HYPOPHYSIS; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OVARY TUMOR; PRIORITY JOURNAL;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, PROGESTERONE;

EID: 0033199889     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (72)

1. Russo, I. H., and Russe. J. Role of hormones in mammary cancer initiation and progression. J. Mammary Gland Biol. Neoplasia, 3: 49-61, 1998.
2. Hirayama, T., and Wynder, E. L. A study of epidemiology of cancer of the breast. II. The influence of hysterectomy. Cancer (Phila.), 15: 28-38, 1962.
3. Feinleib, M. Breast cancer and artificial menopause. J. Natl. Cancer Inst., 41: 315-329, 1968.
4. Trichopoulos, D., MacMahon, B., and Cole, P. Menopause and breast cancer. J. Natl. Cancer Inst., 48: 605-613, 1972.
5. Henderson, B. E., Ross, R. K., Judd, H. L., Krailo, M. D., and Pike, M. C. Do regular ovulatory cycles increase breast cancer risk? Cancer (Phila.), 56: 1206-1208, 1985.
6. Henderson, B. E., Ross, R. K., and Pike, M. C. Hormonal chemoprevention of cancer in women. Science (Washington DC), 259: 633-638, 1993.
7. Clarke, C. L., and Sutherland, R. L. Progestin regulation of cellular proliferation. Endocrine Rev., 11: 266-300, 1990.
8. Laidlaw, I. J., Clarke, R. B., Howell, A., Owen, A., Potten, C. S., and Anderson, E. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology, 136: 164-171, 1995.
9. Anderson, T. S., Ferguson, J. P., and Raab, G. M. Cell turnover in the "resting" human breast: Influence of parity, contraceptive pill, age and laterally. Br. J. Cancer, 46: 376-382, 1982.
10. Pike, M. C., and Spicer, D. V. Contraception. In: D. Shuope and F. Haseltine (eds.), Oral Contraceptives and Cancer, pp. 67-84. New York: Springer-Verlag, 1993.
11. Russo, J., Gusterson, B. A., Rogers, A. E., Russo, I. H., Wellings, S. R., and Van Zwieten, M. J. Comparative study of human and rat mammary tumorigenesis. Lab. Invest., 62: 244-278, 1990.
12. Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Jr., Shyamala, G., Conneely, O. M., and O'Malley, B. W. Mice lacking progesterone receptors exhibit pleiotropic reproductive abnormalities. Genes Dev., 9: 2266-2278, 1995.
13. Lydon, J. P., DeMayo, F. J., Conneely, O. M., and O'Malley, B. W. Reproductive phenotypes of the progesterone receptor null mutant mouse. J. Steroid Biochem. Mol. Biol., 56: 67-77, 1996.
14. Hennighausen, L., and Robinson, G. W. Think globally, act locally: the making of a mouse mammary gland. Genes Dev., 12: 449-455, 1998.
15. Mani, S. K., Allen, J. M. C., Lydon, J. P., Mulac-Jericevic, B., Blaustein, J. D., DeMayo, F. J., Conneely, O. M., and O'Malley, B. W. Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol. Endocrinol., 10: 1728-1737, 1996.
16. Chappell, P. E., Lydon, J. P., Conneely, O. M., O'Malley, B. W., and Levine, J. E. Endocrine defects in mice carrying a null mutation for the progesterone receptor gene. Endocrinology, 138: 4147-4152, 1997.
17. Said, T. K., Conneely, O. M., Medina, D., O'Malley, B. W., and Lydon, J. P. Progesterone, in addition to estrogen, induces cyclin D1 expression in the murine mammary epithelial cell, in vivo. Endocrinology, 138: 3933-3939, 1997.
18. Humphreys, R. C., Lydon, J. P., O'Malley, B. W., and Rosen, J. M. Use of PRKO mice to study the role of progesterone in mammary gland development. J. Mammary Gland Biol. Neoplasia, 2: 343-354, 1997.
19. Humphreys, R. C., Lydon, J. P., O'Malley, B. W., and Rosen, J. M. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol. Endocrinol., 11: 801-811, 1997.
20. Brisken, C., Park, S., Vass, T., Lydon, J. P., O'Malley, B. W., and Weinberg, R. A. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc. Natl. Acad. Sci. USA, 95: 5076-5081, 1998.
21. Cardiff, R. D. Are the TDLU of the human the same as the LA of mice? J. Mammary Gland Biol. Neoplasia, 3: 3-5, 1998.
22. Silberstein, G. B., Van Horn, K., Shyamala, G., and Daniel, C. W. Progesterone receptors in the mouse mammary duct: distribution and developmental regulation. Cell Growth Differ., 7: 945-952, 1996.
23. Shyamala, G., Barcellos-Hoff, M. H., Toft, D., and Yang, X. In situ localization of progesterone receptors in normal mouse mammary glands: absence of receptors in the connective and adipose stroma and a heterogeneous distribution in the epithelium. J. Steroid Biochem. Mol. Biol., 63: 251-259, 1997.
24. Bresciani, F. Topography of DNA synthesis in the mammary gland of the C3H mouse and its control by ovarian hormones: an autoradiographic study. Cell Tissue Kinet., I: 51-63, 1968.
25. Haslam, S. Z. Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinology, 122: 464-470, 1988.
26. Wang, S. L., Counterman, L. J., and Haslam, S. Z. Progesterone action in normal mouse mammary gland. Endocrinology, 127: 2183-2190, 1990.
27. Imagawa, W., Tomooka, Y., Hamamoto, S., and Nandi, S. Stimulation of mammary epithelial cell growth in vitro and interaction of epidermal growth factor and mammogenic hormones. Endocrinology, 116: 1514-1524, 1985.
28. Jull, J. W. The effects of oestrogens and progesterone on the chemical induction of mammary cancer in mice of the IF strain. J. Pathol. Bacteriol., 68: 547-559, 1954.
29. Jabara, A. G., and Harcourt, A. G. Effects of progesterone, ovariectomy and adrenalectomy on mammary tumors induced by 7,12-dimethylbenz(a)anthracene in Sprague-Dawley rats. Pathology, 3: 209-214, 1971.
30. Welsch, C. W. Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res., 45: 3415-3443, 1985.
31. Robinson, S. P., and Jordan, V. C. Reversal of antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mammary carcinoma model. Cancer Res., 47: 5386-5390, 1987.
32. Russo, I. H., and Russo, J. Progestagens and mammary gland development: differentiation versus carcinogenesis. Acta Endocrinol., 125: 7-12, 1991.
33. Aldaz, C. M., Liao, Q. Y., La Bate, M., and Johnston, D. A. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene. Carcinogenesis (Lond.), 17: 2069-2072, 1996.
34. Medina, D. Mammary tumorigenesis in chemical carcinogen-treated mice. J. Incidence in Balb/c and C57BL mice. J. Natl. Cancer Inst., 53: 213-221, 1974.
35. Medina, D., and Warner, M. R. Mammary tumorigenesis in chemical-treated mice. IV. Induction of mammary ductal hyperplasias. J. Natl. Cancer Inst., 57: 331-337, 1976.
36. Medina, D. Serial transplantation of chemical carcinogen-induced mouse mammary ductal hyperplasias. J. Natl. Cancer Inst., 62: 397-405, 1979.
37. Dunn, T. B. Morphology of Mammary Tumors in Mice, Ed. 2, pp. 38-84. New York: Hoeber-Harper, 1959.
38. Church, G. M., and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
39. Vilotte, J-L., Soulier, S., and Mercier, J-C. Sequence of the murine α-lactalbuminencoding cDNA: interspecies comparison of the coding frame and deduced preprotein. Gene (Amst.), 112: 251-255, 1992.
40. Mehta, N. M., El-Gewely, M. R., Joshi, J., Helling, R. B., and Banerjee, M. R. Cloning of mouse β-casein gene sequences. Gene (Amst.), 15: 285-288, 1981.
41. Robinson, G., Johnson, P. F., Hennighausen, L., and Sterneck, E. The C/EBPb transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev., 12: 1907-1916, 1998.
42. Welsch, C. W. Rodent Models to Examine in Vivo Hormonal Regulation of Mammary Gland Tumorigenesis, pp. 163-179. New York: Plenum Press, 1987.
43. Huseby, R. A., Soares, M. J., and Talamantes, F. Ectopic pituitary grafts in mice: hormone levels, effects on fertility, and the development of adenomyosis uteri. Endocrinology, 116: 1440-1448, 1985.
44. Murr, S. M., Stabenfeldt, G. H., Bradford, G. E., and Greschwind, I. I. Plasma progesterone during pregnancy in the mouse. Endocrinology, 94: 1209-1211. 1974.
45. Shyamala, G., Schneider, W., and Schott, D. Developmental regulation of murine mammary progesterone receptor gene expression. Endocrinology, 126: 2882-2889, 1990.
46. Krarup, T. Effect of 9,10-dimethyl-1,2-benzanthracene on the mouse ovary. Ovarian tumorigenesis. Br. J. Cancer, 24: 168-186, 1969.
47. Krarup, T. Effect of 9:10-dimethyl-1:2-benzanthracene on the mouse ovary. Acta Endocrinol., 64: 489-507, 1970.
48. Armuth, V., and Berenblum, I. Mechanism of ovarian carcinogenesis: effect of 7,12-dimethylbenz[a]anthracene administration on intrasplenic ovarian grafts in unilaterally ovariectomized C3HeB/Fe mice. J. Natl. Cancer Inst., 63: 1047-1050, 1979.
49. Geary, C. P. Carcinogen-induced granulosa cell tumors in NZC/BL mice. Pathology, 16: 131-135, 1984.
50. Carter, R. L. Pathology of ovarian neoplasms in rats and mice. Eur. J. Cancer, 3: 537-543, 1968.
51. Moon, R. C. Relationship between previous reproductive history and chemically induced mammary cancer in rats. Int. J. Cancer. 4: 312-317, 1969.
52. Grubbs, C. J., Farnell, D. R., Hill, D. L., and McDonough, K. C. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17β-estradiol and progesterone. J. Natl. Cancer Inst., 74: 927-931, 1985.
53. Grubbs, C. J., Juliana, M. M., Hill, D. L., and Whitaker, L. M. Suppression by pregnancy of chemically induced preneoplastic cells of the rat mammary gland. Anticancer Res., 6: 1395-1400, 1986.
54. Sivaraman, L., Stephens, L. C., Markaverich, B. M., Clark, J. A., Krnacik, S., Conneely, O. M., O'Malley, B. W., and Medina, D. Hormone-induced refractoriness to mammary carcinogenesis in Wister-Furth rats. Carcinogenesis (Lond.), 19: 1573-1581, 1998.
55. Pazos, P., Lanari, C., Meiss, R., Charreau, E. H., and Pasqualini, C. D. Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in Balb/c mice. Breast Cancer Res., 20: 133-138, 1991.
56. Li, S., Leveesque, C., Geng, C-S., Yan, X., and Labrie, F. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. Breast Cancer Res. Treat., 34: 147-159, 1995.
57. Chilvers, C. Breast cancer and depotmedroxprogesterone acetate: a review. Contraception, 49: 211-222, 1994.
58. Guzman, R. C., Osborn, R. C., Swanson, S. M., Sakthivel, R., Hwang, S-I., Miyamoto, S., and Nandi, S. Incidence of c-Ki-ras activation in N-methyl-N-nitrosourea-induced mammary carcinomas in pituitary-isografted mice. Cancer Res., 52: 5732-5737, 1992.
59. Swanson, S. M., Guzman, R. C., Collins, G., Tafoya, P., Thordarson, G., Talamantes, F., and Nandi, S. Refractoriness to mammary carcinogenesis in the parous mouse is reversible by hormonal stimulation induced by pituitary isografts. Cancer Lett., 90: 171-181, 1995.
60. Li, B., Kittrell, F. S., Medina, D., and Rosen, J. M. Delay of dimethylbenz[a]anthracene-induced mammary tumorigenesis in transgenic mice by apoptosis induced by an unusual mutant p53 protein. Mol. Carcinog., 14: 75-83, 1995.
61. Das, R., and Vonderhaar, B. K. Prolactin as a mitogen in mammary cells. J. Mammary Gland Biol. Neoplasia, 2: 29-39, 1997.
62. Welsch, C. W., and Nagasawa, H. Prolactin and murine mammary tumorigenesis: a review. Cancer Res., 37: 951-963, 1977.
63. Stocklin, E., Wissler, M., Gouilleux, F., and Groner, B. Functional interactions between Stat5 and the glucocorticoid receptor. Nature (Lond.), 383: 726-728, 1996.
64. Richer, J. K., Lange, C. A., Manning, N. G., Owen, G., Powell, R., and Horwitz, K. B. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. J. Biol. Chem., 273: 31317-31326, 1998.
65. Smith, G. H. Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of ductal and lobular phenotype. Breast Cancer Res. Treat., 39: 21-31, 1996.
66. Chepko, G., and Smith, G. H. Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell, 29: 239-253, 1997.
67. Swanson, S. M., Guzman, R. C., Christov, K., Miyamoto, S., and Nandi, S. Pituitary-isografted mice are highly susceptible to MNU-induced mammary carcinogenesis irrespective of the level of alveolar differentiation. Carcinogenesis (Lond.), 15: 1341-1346, 1994.
68. DiGiovanni, J., Sawyer, T. W., and Fisher, E. P. Correlation between formation of a specific hydrocarbon-deoxyribonucleoside adduct and tumor-initiating activity of 7,12 dimethylbenz(a)anthracene and its 9-and 10-monofluoroderivatives in mice. Cancer Res., 46: 4336-4341, 1986.
69. Guzman, R. C., Osborn, R. C., Bartley, J. C., and Nandi, S. Metabolism of 7,12-dimethylbenz(a)anthracene by mouse mammary epithelial cells cultured in serum-free inside collagen gels. Cancer Lett., 40: 123-132, 1988.
70. Harvey, M., McArthur, M. J., Montgomery, C. A., Bradley, A., and Donehower, L. A. Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J., 7: 938-943, 1993.
71. Donehower, L. A., Harvey, M., Vogel, H., McArthur, M. J., Montgomery, C. A., Park, S. H., Thompson, T., Ford, R. J., and Bradley, A. Effects of genetic background on tumorigenesis in p53-deficient mice. Mol. Carcinog., 14: 16-22, 1995.
72. Markel, P., Shu, P., Ebeling, C., Carlson, G. A., Nagle, D. L., Smutko, J. S., and Moore, K. J. Theoretical and empiral issues for marker-assisted breeding of congenic mouse strains. Nat. Genet., 17: 280-284, 1997.